Abstract:Since the discovery of antibiotics, penicillin has remained the top choice in clinical medicine. With continuous advancements in biotechnology, penicillin production has become cost-effective and efficient. Genetic engineering techniques have been employed to enhance biosynthetic pathways, leading to the production of new penicillin derivatives with improved properties and increased efficacy against antibiotic-resistant pathogens. Advances in bioreactor design, media formulation, and process optimization have contributed to higher yields, reduced production costs, and increased penicillin accessibility. While biotechnological advances have clearly benefited the global production of this life-saving drug, they have also created challenges in terms of waste management. Production fermentation broths from industries contain residual antibiotics, by-products, and other contaminants that pose direct environmental threats, while increased global consumption intensifies the risk of antimicrobial resistance in both the environment and living organisms. The current geographical and spatial distribution of antibiotic and penicillin consumption dramatically reveals a worldwide threat. These challenges are being addressed through the development of novel waste management techniques. Efforts are aimed at both upstream and downstream processing of antibiotic and penicillin production to minimize costs and improve yield efficiency while lowering the overall environmental impact. Yield optimization using artificial intelligence (AI), along with biological and chemical treatment of waste, is also being explored to reduce adverse impacts. The implementation of strict regulatory frameworks and guidelines is also essential to ensure proper management and disposal of penicillin production waste. This review is novel because it explores the key remaining challenges in antibiotic development, the scope of machine learning tools such as Quantitative Structure-Activity Relationship (QSAR) in modern biotechnology-driven production, improved waste management for antibiotics, discovering alternative path to reducing antibiotic use in agriculture through alternative meat production, addressing current practices, and offering effective recommendations.

Progress on Enhancing Antibiotic Yield by Genetic Engineering

Application of modern biotechnology in antibiotic production

Toward steadfast growth of antibiotic research in China: from natural products to engineered biosynthesis.

Genome Engineering and Modification Toward Synthetic Biology for the Production of Antibiotics

Progression on New Antibiotic Development by Arousing Silent Gene

[Development and High Yield Strategies of Microbial-Derived Antibiotics in Agriculture].

Advances in microbial antimicrobial peptides expression system and transformation strategy

Advances in Genetic Engineering of Domestic Animals

Antibiotic Biosynthetic Pathways And Pathway Engineering - A Growing Research Field In China

Regulatory genes and their roles for improvement of antibiotic biosynthesis in Streptomyces

Advance in Improving the Effects of Probiotics

Progress in strategies for cloning of antibiotics biosynthetic gene clusters

Harnessing biotechnology for penicillin production: Opportunities and environmental considerations

Industrial Production of Antibiotics in Fungi: Current State, Deciphering the Molecular Basis of Classical Strain Improvement and Increasing the Production of High-Yielding Strains by the Addition of Low-Molecular Weight Inducers

[Research progress on strain improvement of Acremonium chrysogenum by genetic engineering]

Genetic Engineering Technologies for Improving Crop Yield and Quality

Engineered biosynthesis of natural products in heterologous hosts.

Metabolic Engineering Strategies Based on Secondary Messengers (p)ppgpp and C-di-GMP to Increase Erythromycin Yield in Saccharopolyspora Erythraea.

Advances on Heterologous Expression of Bacteriocins

Industrial antibiotic-producing actinobacteria: from strain improvement to bioprocess optimization and scale-up

Recent advances in the biosynthesis and production optimization of gentamicin: A critical review